Top Markets
#1 Trillions Trillions +5,128.12%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +165.63%
#4 Siren Siren +128.69%
#5 inSure DeFi inSure DeFi +59.52%
#6 KONET KONET +56.82%
#7 Aria.AI Aria.AI +45.69%
#8 Banana For Scale Banana For Scale +45.24%
#9 Syndicate Syndicate +40.88%
#10 Janction Janction +36.48%
Coin of the day
Trillions Trillions
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Clasificación en acciones #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Precio por acción
$0.09933121
Capitalización bursátil
$29.15K
Cambio (1 día)
0.57%
Cambio (1 año)
449.49%
País
IE
Comercio Ovoca Bio plc (OVB)

Categoría

Healthcare
Ratio P/B de Ovoca Bio plc (OVB)
Ratio P/B al March 2026 TTM: 0.32
Según los informes financieros más recientes y el precio de las acciones de Ovoca Bio plc, el ratio P/B actual (TTM) es 0.32. Al final de 2022, el ratio P/B era 0.64.
Historial del ratio P/B de Ovoca Bio plc desde 2001 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
2026 (TTM) 0.32 5.10%
2023 0.30 -53.15%
2022 0.64 -29.64%
2021 0.91 118.10%
2020 0.42 -3.84%
2019 0.43 -6.34%
2018 0.46 53.47%
2017 0.30 -32.59%
2016 0.45 47.37%
2015 0.30 -7.99%
2014 0.33 9.22%
2013 0.30 -0.88%
2012 0.31 -37.76%
2011 0.49 -30.05%
2010 0.70 56.65%
2009 0.45 86.66%
2008 0.24 -82.53%
2007 1.37 8.35%
2006 1.27 -10.71%
2005 1.42 46.67%
2004 0.97 -4.43%
2003 1.01 -25.12%
2002 1.35 -22.97%
2001 1.76 0.00%
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.6573 1,694.26%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3842 1,924.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.4551 678.66%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.364 1,284.08%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 5.9034 1,772.31%
NL